AZ D702BC00001 Artemide Lung 02: A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum-based Chemotherapy for the First-line Treatment of Patients with Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung02)

Objective

Clinical Trial Details

Principal Investigator(s)

Benjamin Solomon, MD

Clinical Trial Categories

• Cancer
• Lung Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org